Follow
Nuttavut Sumransub
Title
Cited by
Cited by
Year
Advances and new frontiers for immunotherapy in colorectal cancer: Setting the stage for neoadjuvant success?
N Sumransub, K Vantanasiri, A Prakash, E Lou
Molecular Therapy-Oncolytics 22, 1-12, 2021
252021
Periostin regulates autophagy through integrin α5β1 or α6β4 and an AKT‐dependent pathway in colorectal cancer cell migration
S Thongchot, E Singsuksawat, N Sumransub, A Pongpaibul, ...
Journal of Cellular and Molecular Medicine 24 (21), 12421-12432, 2020
232020
Crosstalk between tumor-infiltrating immune cells and cancer-associated fibroblasts in tumor growth and immunosuppression of breast cancer
J Soongsathitanon, P Jamjuntra, N Sumransub, S Yangngam, ...
Journal of Immunology Research 2021, 2021
172021
Breast cancer stem cell RNA‑pulsed dendritic cells enhance tumor cell killing by effector T cells
N Sumransub, N Jirapongwattana, P Jamjuntra, S Thongchot, ...
Oncology Letters 19 (3), 2422-2430, 2020
172020
Putting function back in dysfunction: Endothelial diseases and current therapies in hematopoietic stem cell transplantation and cellular therapies
N Sumransub, N El Jurdi, W Chiraphapphaiboon, JE Maakaron
Blood Reviews 51, 100883, 2022
72022
Checkpoint inhibitor‐based salvage regimens prior to autologous stem cell transplant improve event‐free survival in relapsed/refractory classic Hodgkin lymphoma
SH Desai, MA Spinner, K David, V Bachanova, G Goyal, B Kahl, K Dorritie, ...
American journal of hematology 98 (3), 464-471, 2023
62023
High proliferating regulatory T cells post-transplantation are associated with poor survival in lymphoma patients treated with autologous hematopoietic stem cell transplantation
N Sumransub, Q Cao, R Wangen, C Brunstein, JS Miller, V Bachanova
Transplantation and Cellular Therapy 28 (4), 184. e1-184. e8, 2022
62022
Novel salvage regimens lead to better response and survival in relapsed refractory classic Hodgkin lymphoma after autologous stem cell transplant
SH Desai, MA Spinner, KA David, V Bachanova, G Goyal, J Azzi, ...
Blood 138, 878, 2021
52021
Sarcopenia predicts inferior progression-free survival in lymphoma patients treated with autologous hematopoietic stem cell transplantation
N Sumransub, Q Cao, M Juckett, B Betts, S Holtan, N El Jurdi, M Hu, ...
Transplantation and Cellular Therapy 29 (4), 263. e1-263. e7, 2023
32023
Efficacy of CD19 directed therapies in large B-cell lymphoma (LBCL) relapsing after chimeric antigen receptor (CAR) T-cell therapy
M Iqbal, A Khurana, J Chavez, AC Rosenthal, Z Li, E Craver, S Aditi, ...
Blood 140 (Supplement 1), 10396-10398, 2022
32022
Outcomes of classic Hodgkin lymphoma, relapsed within one year of diagnosis, in the era of novel agents.
S Desai, MA Spinner, KA David, V Bachanova, G Goyal, R Saba, ...
Journal of Clinical Oncology 40 (16_suppl), 7515-7515, 2022
32022
Overall survival of patients with cHL who progress after autologous stem cell transplant: results in the novel agent era
SH Desai, MA Spinner, AM Evens, A Sykorova, V Bachanova, G Goyal, ...
Blood Advances 7 (23), 7295-7303, 2023
22023
Severe hyperammonemia in chimeric antigen receptor T cells recipient—unusual differential diagnosis of encephalopathy syndrome
N Sumransub, F He, D Weisdorf, CJ Billington Jr, A Aggarwal, B Miller, ...
Bone marrow transplantation 57 (2), 286-288, 2022
22022
Overall survival in classic Hodgkin lymphoma pts who progress after autologous stem cell transplant in the era of novel agents
SH Desai, M Spinner, AM Evens, V Bachanova, G Goyal, B Kahl, ...
Hematological Oncology 41, 366-368, 2023
12023
Efficacy of brentuximab consolidation by metabolic response in an international real‐world cohort of classic Hodgkin lymphoma at high risk for progression after ASCT
SH Desai, A Smith, M Spinner, A Sykorova, V Bachanova, AM Evens, ...
Hematological Oncology 41, 361-362, 2023
12023
Sarcopenia Predicts Inferior Progression Free Survival in Lymphoma Patients Treated with Autologous Hematopoietic Stem Cell Transplantation
N Sumransub, Q Cao, M Juckett, BC Betts, SG Holtan, N El Jurdi, M Hu, ...
2022 Tandem Meetings| Transplantation & Cellular Therapy Meetings of ASTCT …, 2022
12022
Multiple malignant tumors in a patient with familial chordoma, a case report
N Sumransub, P Murugan, S Marette, DR Clohisy, KM Skubitz
BMC Medical Genomics 14 (1), 213, 2021
12021
A case of AL amyloidosis presenting with refractory ventricular fibrillation
N Angsubhakorn, A Agdamag, N Sumransub, P Velangi, R Freund, ...
Respiratory Medicine Case Reports 32, 101349, 2021
12021
Kikuchi-Fujimoto disease mimicking T-cell lymphoma after COVID-19 vaccination
N Sumransub, V Bachanova, MA Linden
American Journal of Clinical Pathology, aqae016, 2024
2024
Identification of HLA‐restricted Cytotoxic T Lymphocyte Epitopes of B Cell Maturation Antigen as Promising Peptide Vaccine Candidates for Preventive and Therapeutic Strategies …
W Chiraphapphaiboon, P Luangwattananun, T Chieochansin, ...
Advanced Therapeutics 7 (2), 2300208, 2024
2024
The system can't perform the operation now. Try again later.
Articles 1–20